Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00797056 · ClinicalTrials.gov registry record · Early Phase 1
Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease
A Early Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 32
- Enrollment target
NCT00797056 is a Early Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 32 participants.
The verdict
NCT00797056, a Early Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study is designed to test the use of G-CSF in peripheral vascular disease. The investigators hypothesize that mobilization of angiogenic cells into the blood by granulocyte colony stimulating factor (G-CSF) may stimulate the formation of new blood vessels and result in a sustained improvement in blood flow in patients with severe peripheral arterial disease.
Interventions
- DRUG Placebo
- DRUG G-CSF
- DRUG Aspirin
- DRUG Clopidogrel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00797056
The ClinicalTrials.gov registry entry for NCT00797056 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00797056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00797056 about?
NCT00797056 is a clinical study titled "Stem Cell Mobilization by G-CSF to Treat Severe Peripheral Artery Disease". This study is designed to test the use of G-CSF in peripheral vascular disease. The investigators hypothesize that mobilization of angiogenic cells into the blood by granulocyte colony stimulating factor (G-CSF) may stimulate the formation of new blood vessels and result in a sustained improvement i...
What is the current status of trial NCT00797056?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 32 participants. The study started on 2008-04. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00797056?
The interventions under investigation include: Placebo (DRUG), G-CSF (DRUG), Aspirin (DRUG), Clopidogrel (DRUG).
Who is sponsoring clinical trial NCT00797056?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.